Phase 3 Trials Reveal New Standards of Care for NSCLC

Data from several recent phase 3 trials support changes to standard care for NSCLC, according to researchers. Data from several recent phase 3 trials support changes to standard care for NSCLC, according to researchers.

Related Keywords

Massachusetts , United States , South Korea , Boston , Seoul , Soult Ukpyolsi , Republic Of Korea , Byoung Chul Cho , Zosia Piotrowska , Yonsei University , Amivantamab Plus Lazertinib , Massachusetts General Hospital ,